Method of using aminocyanopyridine compounds as mitogen activated protein kinase-activated protein kinase-2 inhibitors
申请人:Pharmacia Corporation
公开号:US20040127519A1
公开(公告)日:2004-07-01
A method is described for inhibiting mitogen activated protein kinase-activated protein kinase-2 in a subject in need of such inhibition, where the method involves administering to the subject an anminocyanopyridine MK-2 inhibiting compound, or a pharmaceutically acceptable salt thereof.
Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2
申请人:Pharmacia Corporation
公开号:US20040142978A1
公开(公告)日:2004-07-22
Aminocyanopyridine compounds are described which can inhibit mitogen activated protein kinase-activated protein kinase-2. Pharmaceutical compositions and kits that contain these compounds are also described.
METHOD OF USING AMINOCYANOPYRIDINE COMPOUNDS AS MITOGEN ACTIVATED PROTEIN KINASE-ACTIVATED PROTEIN KINASE-2 INHIBITORS
申请人:Pharmacia Corporation
公开号:EP1569645A2
公开(公告)日:2005-09-07
AMINOCYANOPYRIDINE INHIBITORS OF MITOGEN ACTIVATED PROTEIN KINASE-ACTIVATED PROTEIN KINASE-2
申请人:Pharmacia Corporation
公开号:EP1569932A1
公开(公告)日:2005-09-07
[EN] METHOD OF USING AMINOCYANOPYRIDINE COMPOUNDS AS MITOGEN ACTIVATED PROTEIN KINASE-ACTIVATED PROTEIN KINASE-2 INHIBITORS<br/>[FR] PROCEDE D'UTILISATION DE COMPOSES D'AMINOCYANOPYRIDINE EN TANT QU'INHIBITEURS DE LA PROTEINE MAPKAP KINASE-2
申请人:PHARMACIA CORP
公开号:WO2004054505A2
公开(公告)日:2004-07-01
A method is described for inhibiting mitogen activated protein kinase-activated protein kinase-2 in a subject in need of such inhibition, where the method involves administering to the subject an anminocyanopyridine MK-2 inhibiting compound, or a pharmaceutically acceptable salt thereof.